Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.79 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.79 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.79 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | CNR1 | P21554 | 1/20 | 0.64 |
| ▸ | CNR2 | P34972 | 1/20 | 0.64 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13481433 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934740 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934675 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934864 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29935123 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2581704 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934264 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934263 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29934738 | 1.00 | PRKCA (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29651586 | 0.99 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7547455-B2 | Cancer and inflammatory disorder treatment | ACADEMIA SINICA (TW) | 2009-06-16 | — | — | US | claimed |
| US-20080152737-A1 | CANCER AND INFLAMMATORY DISORDER TREATMENT | ACADEMIA SINICA (TW) | 2008-06-26 | — | — | US | claimed |
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-02-06 | — | — | US | disclosed |
| WO-2024211809-A1 | METHODS AND COMPOSITIONS FOR INCREASING PROTEIN AND/OR OIL CONTENT AND/OR OIL PROFILE IN A PLANT | SYNGENTA CROP PROTECTION AG (CH) | 2024-10-10 | — | — | WO | disclosed |
| CN-115308340-B | Method for detecting cold-resistant marker in winter rape overwintering period and application | 甘肃农业大学 | 2023-11-14 | — | — | CN | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| US-8048455-B2 | Treatment of cancer and inflammatory disorder | ACADEMIA SINICA (TW) | 2011-11-01 | — | — | US | disclosed |
| US-20110064794-A1 | Drug Delivery System, its Preparation Process and Use | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2011-03-17 | — | — | US | disclosed |
| US-20100317603-A1 | Treatment of Cancer and Inflammatory Disorder | ACADEMIA SINICA (TW) | 2010-12-16 | — | — | US | disclosed |
| US-7547455-B2 | Cancer and inflammatory disorder treatment | ACADEMIA SINICA (TW) | 2009-06-16 | — | — | US | disclosed |
| US-20080152737-A1 | CANCER AND INFLAMMATORY DISORDER TREATMENT | ACADEMIA SINICA (TW) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | FABP2, NSUN2, TRDMT1 | PRKCA 1593/4885PRKCE 3068/4885PRKCQ 2159/4885 |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | PRKCA 2378/4885PRKCE 3922/4885PRKCQ 3379/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | PRKCA 55/4885PRKCE 194/4885PRKCQ 343/4885 |
| US-20250041423-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | CHMP4B, EXOSC5, FIP1L1 | PRKCA 164/4885PRKCE 846/4885PRKCQ 902/4885 |
| US-20100317603-A1 | Treatment of Cancer and Inflammatory Disorder | TNF, LITAF, NFKBIA | PRKCA 2002/4885PRKCE 1988/4885PRKCQ 2327/4885 |
| US-20080152737-A1 | CANCER AND INFLAMMATORY DISORDER TREATMENT | TNF, NFKBIA, RELA | PRKCA 2164/4885PRKCE 2183/4885PRKCQ 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.